Author Archives: Warren Woessner

Bristol-Myers Squibb v. Merck – Mayo/Alice Rule Reaches Medical Treatment Methods.

In Bristol-Myers Squibb v. Merck, Civil Action No. 150572-GMS (D. Del., 2016), Bristol-Myers sued Merck for inducing infringement of U.S. Pat. No. 9,073,994. Claim 1 reads: “A method of treating a metastatic melanoma comprising intravenously administering an effective amount of … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | 3 Comments

Superman Breyer v. Batman Lourie Battle in the Sequenom Petition for Cert.

Since this is an amplification of my last post on the Sequenom petition for cert. in Sequenom v. Ariosa, please go back at read my first post on the petition. I have been arguing for some years that the patent … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Sequenom Files Petition for Cert. After Invalidation of Cff Patent

Sequenom, the loser in “Ariosa,” has filed a petition seeking Supreme Court review of the Fed. Cir.’s invalidation of the claims of US Pat. No. 6,258,540 as an attempt to claim a natural product, cffDNA. While there is no dispute … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

Takeaways From Chisum Patent Academy March 2016 Seminar

Takeaways from Our March 2016 Cincinnati Seminar By Donald S. Chisum and Janice M. Mueller Copyright 2016 Chisum Patent Academy, Inc. On March 10-11, 2016 the Chisum Patent Academy held a small-group seminar at the 21C Museum Hotel in Cincinnati, … Continue reading

Posted in Miscellaneous | Tagged , , , , , , | Leave a comment